Kashanchi lab has recently obtained multiple fundings on HIV, HTLV and EV diagnostic and therapeutic research. The fundings total more than a million dollars a year for multiple years and are from NIH, Campbell Foundation, and DOD. The topics range from silencing of HIV in the brains of infected individuals; detection of EVs from gut microbiome and its connection to CNS in HIV patients (Collaboration with University of Miami); Use of EVs from Babesia infected cells for vaccines (Collaboration with Yale and ATCC); Use of immune therapy on HTLV-1 infected cells; and detection of specific modified RNA in HIV-1 infected cells (Collaboration with Harvard).
